chr5-140114160-CGCGGCAGCGGAGCGCAGCATCATGGCGGACCGAGACA-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_005859.5(PURA):c.-12_25del variant causes a start lost, 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 31)
Consequence
PURA
NM_005859.5 start_lost, 5_prime_UTR
NM_005859.5 start_lost, 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.21
Genes affected
PURA (HGNC:9701): (purine rich element binding protein A) This gene product is a sequence-specific, single-stranded DNA-binding protein. It binds preferentially to the single strand of the purine-rich element termed PUR, which is present at origins of replication and in gene flanking regions in a variety of eukaryotes from yeasts through humans. Thus, it is implicated in the control of both DNA replication and transcription. Deletion of this gene has been associated with myelodysplastic syndrome and acute myelogenous leukemia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-140114160-CGCGGCAGCGGAGCGCAGCATCATGGCGGACCGAGACA-C is Pathogenic according to our data. Variant chr5-140114160-CGCGGCAGCGGAGCGCAGCATCATGGCGGACCGAGACA-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 974857.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PURA | NM_005859.5 | c.-12_25del | start_lost, 5_prime_UTR_variant | 1/1 | ENST00000331327.5 | NP_005850.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PURA | ENST00000331327.5 | c.-12_25del | start_lost, 5_prime_UTR_variant | 1/1 | NM_005859.5 | ENSP00000332706 | P1 | |||
PURA | ENST00000502351.1 | c.-12_25del | start_lost, 5_prime_UTR_variant | 2/2 | 2 | ENSP00000498760 | ||||
PURA | ENST00000505703.2 | c.-12_25del | start_lost, 5_prime_UTR_variant | 2/2 | 3 | ENSP00000498560 | ||||
PURA | ENST00000651386.1 | c.-12_25del | start_lost, 5_prime_UTR_variant | 2/2 | ENSP00000499133 | P1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at